Novo Nordisk signs up to $2.1 billion licensing deal with Omeros in rare disease push
(Reuters) -Danish drugmaker Novo Nordisk and Omeros have signed a licensing deal worth up to $2.1 bi...
15th October, 2025
(Reuters) -Danish drugmaker Novo Nordisk and Omeros have signed a licensing deal worth up to $2.1 bi...
15th October, 2025
BENGALURU (Reuters) -India's Infosys said on Tuesday it has won a 1.2 billion pound ($1.59 billion)...
14th October, 2025
By Patrick Wingrove (Reuters) -Johnson & Johnson on Tuesday raised its 2025 sales forecast after rep...
14th October, 2025
By Maggie Fick LONDON (Reuters) -AstraZeneca CEO Pascal Soriot looked relaxed standing in the Oval O...
12th October, 2025
By Steve Holland and Michael Erman WASHINGTON (Reuters) -President Donald Trump unveiled a deal with...
10th October, 2025
By Maggie Fick LONDON (Reuters) -AstraZeneca broke ground on a new plant in Virginia on Thursday and...
9th October, 2025
STOCKHOLM (Reuters) -Danish drugmaker Novo Nordisk said on Thursday it had agreed to buy United Stat...
9th October, 2025
BERLIN (Reuters) -Germany's cabinet passed plans on Wednesday to restrict the online sale of cannabi...
8th October, 2025
(Corrects day in paragraph 1) (Reuters) -AstraZeneca said on Tuesday its experimental drug baxdrosta...
7th October, 2025
STOCKHOLM (Reuters) -Scientists Mary Brunkow, Fred Ramsdell and Shimon Sakaguchi won the 2025 Nobel...
6th October, 2025
(Reuters) -Danish drugmaker Novo Nordisk said it plans to make its new obesity pill available throug...
3rd October, 2025

Choosing a family health insurance plan is a big decision. It is a safety net that protects your lov...
3rd October, 2025